ReviewJournal of diabetes investigation2021

Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients.

Atsunori Kashiwagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.